Dermatology Market

Dermatology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028


Global Dermatology Market has valued at USD 1.32 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 6.62% through 2028. The global dermatology market is a dynamic and rapidly evolving sector that plays a pivotal role in addressing a wide array of skin-related conditions and disorders. Characterized by a robust combination of technological advancements, increasing awareness, and a growing aging population, the dermatology market has witnessed substantial growth in recent years. The market encompasses a broad spectrum of products and services, ranging from pharmaceuticals and biologics to diagnostic devices and cosmetic interventions. One of the key drivers fueling the expansion of the dermatology market is the rising incidence of skin diseases, including dermatitis, psoriasis, acne, and skin cancer, necessitating a heightened demand for effective treatment options. Furthermore, the growing emphasis on aesthetic procedures and cosmetic dermatology has contributed significantly to market growth, driven by the increasing consumer desire for youthful and healthy skin.

In addition to traditional treatments, technological innovations have spurred the development of novel therapies, such as targeted biologics and personalized medicine, transforming the landscape of dermatological care. The market is witnessing a surge in research and development activities, fostering the discovery of innovative therapies and treatment modalities. Geographically, North America and Europe have traditionally held substantial market shares, owing to advanced healthcare infrastructure, a high prevalence of skin disorders, and a proactive approach to skincare. However, emerging economies in Asia-Pacific and Latin America are rapidly gaining traction, driven by an expanding middle-class population, rising disposable income, and increasing awareness about dermatological health.

Collaborations, partnerships, and strategic acquisitions are prevalent strategies among industry participants to strengthen their market foothold and expand their product portfolios. Overall, the global dermatology market is poised for continued growth, fueled by a combination of demographic trends, technological advancements, and evolving consumer preferences, making it a vital and vibrant sector within the broader healthcare industry.

Key Market Drivers

Increasing Incidence of Skin Disorders Worldwide

The global dermatology market is witnessing a substantial boost, driven in large part by the increasing incidence of skin disorders worldwide. Skin conditions, ranging from common ailments like dermatitis and acne to more serious issues such as psoriasis and skin cancer, have become more prevalent across diverse demographics. This upsurge can be attributed to a combination of factors, including environmental changes, lifestyle choices, and genetic predispositions. As the global population expands and ages, there is a parallel rise in the demand for effective dermatological treatments and interventions.

The prevalence of skin disorders has become a significant public health concern, prompting a heightened focus on dermatology as a crucial facet of healthcare. Skin conditions not only impact physical well-being but also carry a substantial psychological and emotional burden. This has led to an increased awareness among individuals about the importance of seeking professional dermatological care, thereby driving the demand for dermatological products and services. As a result, the pharmaceutical industry is responding with a growing array of medications, including topical treatments, oral medications, and biologics, designed to address specific skin conditions and improve patient outcomes.

The surge in skin disorders is also influencing the development of advanced diagnostic technologies and treatment modalities within the dermatology market. Innovations such as telemedicine and digital health platforms are facilitating improved access to dermatological expertise, enabling patients to seek consultations remotely. Moreover, the integration of artificial intelligence and machine learning in dermatological diagnostics is enhancing the accuracy and efficiency of disease detection. Early diagnosis is crucial in managing skin disorders effectively, and these technological advancements contribute significantly to the overall growth and competitiveness of the dermatology market.

The global dermatology market is witnessing a paradigm shift not only in response to the increasing prevalence of skin disorders but also due to changing societal perceptions. The recognition of the impact of skin conditions on quality of life has fueled a growing demand for cosmetic dermatology procedures. Individuals are seeking aesthetic treatments to address concerns related to aging, pigmentation, and overall skin appearance. This burgeoning interest in cosmetic interventions, including injectables, laser therapies, and surgical procedures, is opening new avenues for dermatologists and contributing to the diversification of the dermatology market.

Technological Advancements

Technological advancements are playing a transformative role in propelling the global dermatology market to new heights. The integration of cutting-edge technologies has significantly enhanced the diagnosis, treatment, and overall management of dermatological conditions, fostering a paradigm shift in healthcare solutions. One of the notable contributions comes from the realm of telemedicine and digital health platforms, which have revolutionized the way dermatological care is delivered. These technologies enable remote consultations, allowing patients to access specialized dermatological expertise regardless of geographical barriers. This not only enhances patient convenience but also facilitates timely interventions and reduces the burden on traditional healthcare infrastructures.

In the field of diagnostics, technological innovations have brought about remarkable improvements in accuracy and efficiency. Techniques such as dermoscopy and reflectance confocal microscopy have revolutionized skin cancer diagnosis, providing dermatologists with powerful tools for early detection and precise assessment. Artificial intelligence (AI) and machine learning algorithms are being increasingly employed to analyze dermatological images, assisting in the identification of patterns indicative of various skin conditions. This not only aids in faster and more accurate diagnostics but also contributes to the overall efficiency of dermatological care.

Moreover, advancements in treatment modalities are reshaping the therapeutic landscape of dermatology. Targeted biologics, personalized medicine, and innovative pharmaceuticals are emerging as more effective and precise interventions for various skin disorders. These developments signify a shift toward customized treatment plans, addressing individual patient needs and characteristics. The market is witnessing a surge in research and development activities aimed at discovering novel therapies that leverage the latest scientific and technological breakthroughs, thereby expanding the array of options available to dermatologists and their patients.

The incorporation of technology also extends to patient education and engagement. Digital platforms and mobile applications provide valuable resources for individuals seeking information on skincare, preventive measures, and treatment options. These tools empower patients to actively participate in their dermatological care, fostering a collaborative approach between healthcare providers and patients. The increased accessibility to information contributes to heightened awareness about skin health, leading to proactive measures and early intervention.

Increasing Awareness of Aesthetic Dermatology Procedures

The global dermatology market is experiencing a significant uplift driven by the increasing awareness of aesthetic dermatology procedures. Aesthetic concerns and the desire for enhanced physical appearance have become prominent factors influencing consumer choices in the realm of dermatological interventions. Individuals are increasingly seeking cosmetic dermatology procedures to address a variety of aesthetic issues, including signs of aging, pigmentation irregularities, and overall skin quality. This heightened awareness is fueling a surge in demand for a diverse range of aesthetic treatments, ranging from minimally invasive procedures such as injectables and laser therapies to more extensive surgical interventions.

The growing acceptance of aesthetic dermatology is reshaping the market dynamics, with a notable shift in consumer preferences towards treatments that offer natural-looking results and minimal downtime. The market response to this trend has been the development of advanced and innovative cosmetic interventions designed to cater to diverse patient needs. Injectables like botulinum toxin and dermal fillers are witnessing a robust demand, providing non-surgical options for facial rejuvenation and volume restoration. Laser and light-based therapies are gaining popularity for addressing skin imperfections and promoting collagen production. Additionally, surgical procedures such as facelifts and body contouring are becoming more commonplace as individuals seek comprehensive solutions for aesthetic enhancement.

The rise in awareness of aesthetic dermatology is not only influencing individual choices but is also driving the growth of specialized dermatology practices and clinics dedicated to cosmetic procedures. Dermatologists and healthcare professionals are adapting to this evolving landscape by expanding their expertise and offering a broader array of aesthetic services. The market is witnessing a convergence of medical and cosmetic dermatology, with practitioners adopting a holistic approach to address both medical and aesthetic concerns, thereby catering to the diverse needs of their patient base.

Furthermore, the influence of social media and digital platforms is playing a pivotal role in spreading awareness about aesthetic dermatology procedures. Before-and-after photos, patient testimonials, and educational content shared on these platforms contribute to an informed and engaged audience. Patients are increasingly researching and seeking information online, leading to a more educated consumer base that actively participates in decisions related to their aesthetic treatments.

Key Market Challenges

Economic Burden Associated with Dermatological Treatments

The economic burden associated with dermatological treatments stands out as a significant impediment hindering the global dermatology market. As the market witnesses the emergence of cutting-edge therapies, including biologics and advanced pharmaceuticals, the high costs of research, development, and production contribute to elevated pricing, limiting accessibility for a substantial portion of the population.

In developed countries, where healthcare resources are relatively abundant, the economic challenge manifests in the form of high out-of-pocket expenses for patients seeking dermatological care. The affordability of these treatments becomes a pressing concern, especially for those without comprehensive insurance coverage. This economic barrier not only restricts patient access to innovative therapies but also places a strain on healthcare systems, leading to disparities in the quality of dermatological care based on socioeconomic factors.

In developing nations, the economic burden poses an even more formidable challenge. Limited healthcare resources and infrastructure, coupled with a lack of insurance coverage, make advanced dermatological treatments a luxury rather than a necessity for many individuals. Skin disorders, which can significantly impact quality of life, often go untreated due to financial constraints. This not only results in prolonged suffering for affected individuals but also contributes to the overall burden of untreated dermatological conditions on public health.

Regulatory hurdles

Regulatory hurdles are a formidable obstacle impeding the seamless growth of the global dermatology market. The journey from the inception of innovative dermatological products to their commercialization is often prolonged and arduous due to stringent regulatory requirements. While these regulations are crucial for ensuring the safety and efficacy of dermatological treatments, the complex and time-consuming approval processes can significantly delay the introduction of novel solutions to the market.

The regulatory landscape for dermatological products is characterized by rigorous testing and documentation requirements. Pharmaceutical companies and manufacturers must adhere to strict protocols to demonstrate the safety and effectiveness of their products before gaining regulatory approval. This meticulous approach, while essential for protecting patient well-being, inevitably extends the time and resources required for bringing new dermatological therapies to market.

Additionally, the divergent regulatory standards across different regions and countries present a significant challenge for industry players aiming for global market penetration. Navigating the intricacies of varied regulatory frameworks demands substantial investments in legal and regulatory affairs expertise, further complicating the pathway to market approval. The variations in regulatory standards not only extend the timelines for product approvals but also create barriers to entry, limiting the accessibility of innovative dermatological treatments for patients in certain regions.

Key Market Trends

Surge in Cosmetic Procedures and Dermatological Surgeries

The global dermatology market is experiencing a surge driven by the increasing demand for cosmetic procedures and dermatological surgeries. This trend is indicative of a cultural shift where individuals are placing a higher emphasis on aesthetic enhancements and skin rejuvenation. Non-invasive cosmetic procedures, such as injectables (e.g., dermal fillers and neurotoxins like Botox) and laser therapies, have become immensely popular due to their effectiveness in addressing signs of aging and enhancing facial features. The allure of these minimally invasive treatments lies in their ability to deliver noticeable results with minimal downtime, catering to individuals seeking quick and convenient solutions for aesthetic improvements.

Dermatological surgeries, including facelifts, eyelid surgery, and liposuction, are also on the rise. These procedures offer more comprehensive and long-lasting results, addressing a range of concerns beyond what non-invasive treatments can achieve. The increasing acceptance and destigmatization of cosmetic procedures contribute to a growing patient pool opting for dermatological surgeries to achieve their desired aesthetic outcomes. Moreover, advancements in surgical techniques and technology have made these procedures safer and more accessible, attracting a broader demographic of patients.

The surge in cosmetic procedures and dermatological surgeries is driven by a desire for enhanced self-esteem and confidence, coupled with a societal appreciation for aesthetic diversity. As the global population ages, there is a heightened awareness of the impact of aging on one's appearance, fueling the demand for anti-aging solutions. The influence of social media, where visual representation holds significant value, further contributes to the popularity of cosmetic interventions.

Technological Integration in Teledermatology

The global dermatology market is experiencing a significant boost propelled by the integration of technology, particularly in the realm of teledermatology. This innovative approach to dermatological care involves the use of digital platforms and telecommunication technologies to facilitate remote consultations, diagnosis, and treatment planning. The convergence of technology and dermatology not only addresses barriers to traditional healthcare access but also enhances the overall efficiency and reach of dermatological services.

Teledermatology is reshaping patient care by allowing individuals to consult with dermatologists from the comfort of their homes. This is particularly advantageous in areas with limited access to specialized dermatological services or during situations like the COVID-19 pandemic, where in-person visits may be challenging. The integration of high-quality imaging tools, such as dermoscopes, enables patients to capture and share images of skin conditions with dermatologists, facilitating accurate and timely remote assessments.

Furthermore, the rise of artificial intelligence (AI) and machine learning in teledermatology is revolutionizing the diagnostic process. These technologies analyze dermatological images, aiding in the identification of patterns indicative of various skin conditions. The automation of certain diagnostic tasks not only enhances the accuracy of assessments but also expedites the overall diagnostic process, contributing to timely and effective patient care.

The global adoption of teledermatology is facilitated by the increasing prevalence of smartphones and internet connectivity. Mobile applications and telehealth platforms dedicated to dermatology provide patients with user-friendly interfaces, allowing them to schedule virtual appointments, share images securely, and receive expert guidance. This technological integration not only improves patient convenience but also fosters a proactive approach to skincare, as individuals can seek dermatological advice promptly.

Segmental Insights

Application Insights

Based on the Application, Acne emerged as the dominant segment in the global market for Global Dermatology in 2022. Acne is one of the most prevalent skin conditions globally. It affects individuals of various age groups, and its widespread occurrence drives the demand for effective treatments. The condition can range from mild to severe, leading individuals to seek dermatological care for personalized solutions. Acne can have a profound psychosocial impact, affecting self-esteem and quality of life. Individuals often seek dermatological interventions not only for the physical symptoms but also to address the emotional and psychological aspects associated with acne. This contributes to a sustained demand for acne-related treatments. Increasing awareness about skincare and dermatological health has led individuals to proactively seek solutions for acne.

Type Insights

Based on the Type, Cosmetic Dermatology emerged as the dominant segment in the global market for Global Dermatology Market in 2022. The increasing emphasis on aesthetic concerns and the desire for cosmetic enhancements contribute significantly to the popularity of cosmetic dermatology procedures. As societal attitudes evolve, there is a growing acceptance and destigmatization of cosmetic interventions, leading to a surge in demand for treatments that address signs of aging, pigmentation issues, and overall skin appearance.The appeal of cosmetic dermatology lies in its ability to offer non-invasive or minimally invasive procedures that yield visible and often immediate results.

Regional Insights

North America emerged as the dominant player in the Global Dermatology Market in 2022, holding the largest market share. The cultural emphasis on aesthetics and youthfulness has driven a significant demand for cosmetic dermatology procedures. North America leads in the adoption of cosmetic interventions, including injectables, laser therapies, and other aesthetic treatments, contributing substantially to the overall dermatology market. The region is home to numerous pharmaceutical and biotechnology companies actively engaged in dermatology research and development. Ongoing efforts to innovate and introduce new therapeutic options have propelled North America to the forefront of dermatological advancements.

Key Market Players

AbbVie Inc.

Pfizer Inc.

GSK plc

LEO Pharma A/S

Sun Pharmaceutical Industries Ltd

Galderma S.A.

Amgen Inc.

DermBiont, Inc.

Johnson & Johnson Services Inc.

Roivant Sciences Ltd

Report Scope:

In this report, the Global Dermatology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
  • Global Dermatology Market, By Type:
  • Medical Dermatology
  • Surgical Dermatology
  • Pediatric Dermatology
  • Cosmetic Dermatology
  • Cutaneous Lymphoma
  • Dermatoimmunology
  • Others
  • Global Dermatology Market, By Application:
  • Acne
  • Dermatitis
  • Psoriasis
  • Skin Cancer
  • Rosacea
  • Alopecia
  • Others
  • Global Dermatology Market, By End User:
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others
  • Global Dermatology Market, By Region:
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt
Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dermatology Market.

Company Information
  • Detailed analysis and profiling of additional market players (up to five).
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights


1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Dermatology Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Type (Medical Dermatology, Surgical Dermatology, Pediatric Dermatology, Cosmetic Dermatology, Cutaneous Lymphoma, Dermatoimmunology, Others)
4.2.2. By Application (Acne, Dermatitis, Psoriasis, Skin Cancer, Rosacea, Alopecia, Others)
4.2.3. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
4.2.4. By Region
4.2.5. By Company (2022)
4.3. Market Map
4.3.1. By Type
4.3.2. By Application
4.3.3. By End User
4.3.4. By Region
5. Asia Pacific Dermatology Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type
5.2.2. By Application
5.2.3. By End User
5.2.4. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Dermatology Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Type
5.3.1.2.2. By Application
5.3.1.2.3. By End User
5.3.2. India Dermatology Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Type
5.3.2.2.2. By Application
5.3.2.2.3. By End User
5.3.3. Australia Dermatology Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Type
5.3.3.2.2. By Application
5.3.3.2.3. By End User
5.3.4. Japan Dermatology Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Type
5.3.4.2.2. By Application
5.3.4.2.3. By End User
5.3.5. South Korea Dermatology Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Type
5.3.5.2.2. By Application
5.3.5.2.3. By End User
6. Europe Dermatology Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Application
6.2.3. By End User
6.2.4. By Country
6.3. Europe: Country Analysis
6.3.1. France Dermatology Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Germany Dermatology Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Spain Dermatology Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Application
6.3.3.2.3. By End User
6.3.4. Italy Dermatology Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Type
6.3.4.2.2. By Application
6.3.4.2.3. By End User
6.3.5. United Kingdom Dermatology Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Type
6.3.5.2.2. By Application
6.3.5.2.3. By End User
7. North America Dermatology Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Dermatology Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. Mexico Dermatology Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. Canada Dermatology Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Application
7.3.3.2.3. By End User
8. South America Dermatology Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Dermatology Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. Argentina Dermatology Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. Colombia Dermatology Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Application
8.3.3.2.3. By End User
9. Middle East and Africa Dermatology Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Dermatology Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. Saudi Arabia Dermatology Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. UAE Dermatology Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Application
9.3.3.2.3. By End User
9.3.4. Egypt Dermatology Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Type
9.3.4.2.2. By Application
9.3.4.2.3. By End User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. Global Dermatology Market: SWOT Analysis
13. Porter’s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Product
14. Competitive Landscape
14.1. AbbVie Inc.
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Current Capacity Analysis
14.1.5. Financials (In case of listed)
14.1.6. Recent Developments
14.1.7. SWOT Analysis
14.2. Pfizer Inc.
14.3. GSK plc
14.4. LEO Pharma A/S
14.5. Sun Pharmaceutical Industries Ltd
14.6. Galderma S.A.
14.7. Amgen Inc.
14.8. DermBiont, Inc.
14.9. Johnson & Johnson Services Inc.
14.10. Roivant Sciences Ltd
15. Strategic Recommendations
16. About Us & Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings